Healthcare · Revenue & Growth
Deploy an AI Agent for Lead Qualification in Medical Devices
We design, build, and run AI-native lead qualification for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native lead qualification for medical devices is a phased engagement (Discovery 2 weeks → Build 9 weeks → Run continuous (integration-heavy)) that ships a production workflow on top of QMS and CRM, moves speed to lead by −75% against the medical devices baseline, and is operated under revenue & growth governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Lead Qualification
- Intent cluster
- Revenue & Growth
- Primary KPI
- speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction
- Top benchmark
- Lead-to-meeting cycle time: 11.4 days → 2.8 days (−75%)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 2 weeks → Build 9 weeks → Run continuous (integration-heavy)
- Team size
- 1 senior delivery + 1 part-time domain SME
- Discovery price
- $5k · 2-week sprint
- Build price
- $15k–$22k · 6-8 weeks
Primary outcome
separate serious buyers from noise faster
What we ship
AI qualification assistant, scoring rubric, routing rules, and CRM governance
KPIs we report on
speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction
Why Medical Devices teams hire us for this
Medical Devices buyers we talk to share a common frustration: too many AI vendor demos, too few production deployments that survive a quarterly review. AI-native lead qualification is the answer to that gap — every engagement we ship is designed to pass a CFO's challenge, a risk officer's review, and an operator's daily use, simultaneously.
Across medical devices sales orgs we have benchmarked, the conversion floor from MQL to SQL hovers around 12-18% — most of the leakage happens at first-touch quality. That is the layer AI-native systems compress fastest.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of lead qualification in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Lead-to-meeting cycle time Median across Salesforce-reporting B2B teams; AI-native compression validated on first thin-slice deployment | 11.4 days | 2.8 days | −75% |
Outbound reply rate Industry baseline from Gartner B2B Sales Pulse; AI-native lift from per-prospect context injection | 1.2% | 4.1% | +3.4× |
SDR throughput (qualified meetings / week) Same SDR headcount, AI handles research + first-touch drafting | 4–6 | 14–22 | +3× |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
The control surface we ship for lead qualification is built from the start to be operated by your team, not by us. Each prompt and rule has a named owner, each reviewer queue has an SLA, each metric has a dashboard. By the end of the first Run quarter, your operators can adjust thresholds and refresh sources without us in the loop — we stay available for the architecture-level decisions.
What we build inside the workflow
What makes lead qualification survive its first production quarter in medical devices is not the prompt — it is the surrounding scaffolding. We allocate at least 40% of the Build budget to non-model engineering: data access, source curation, eval harness, reviewer UI, audit logging. Counterintuitive on a "prompt engineering" timeline, but it is the only configuration where the workflow holds up past month three.
Reference architecture
4-layer AI-native workflow for revenue & growth
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Revenue & Growth →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for lead qualification in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | +3.4× |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Revenue engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$5k
2-week sprint
Phase 2 · Build
$15k–$22k
6-8 weeks
Phase 3 · Run
$2k–$3k / mo
optional, hourly bank also available
~$25k–$45k typical year 1 (60% take the run option for ~6 months)
Outbound, growth, or revenue-ops workflow, integration with your CRM, weekly operating review during Run.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for lead qualification
Reference inputs below are typical for medical devices teams in the revenue cluster. Adjust them to match your situation.
Projected
Current monthly cost
$24,000
AI-native monthly cost
$7,920
Annual savings
$192,960
67% cost reduction · ~468 operator-hours freed / month
Governance and risk controls
Governance is not a phase, it is a layer. From the first Discovery interview, we capture the risk lens — for medical devices, that includes quality management, clinical claims, product support, training accuracy, and complaint handling. The architecture decisions in Build (source curation, prompt versioning, reviewer SLA, audit log retention) follow from that lens. By the time Run starts, the controls are part of the operating cadence, not a compliance overlay.
How we report ROI
For medical devices CFOs, the ROI question is usually about three numbers: cost per transaction, error rate, and time-to-decision. We instrument all three during Build, surface them in the operating dashboard, and report against the Discovery baseline weekly. speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction is the bridge between the engagement and the P&L.
Common pitfall & mitigation
The failure mode we see most often on AI-native lead qualification engagements in medical devices contexts.
Volume without quality
Teams scale outbound 5× but reply rate collapses because the AI sends generic pitches
Per-prospect context retrieval (intent data + recent triggers) before any draft. Reviewer queue on first 500 sends to calibrate.
Build internally or work with us
For medical devices CTOs already running an ML platform, the value we bring is not engineering — it is the operating model and the productized governance stack. We have shipped enough variations of this workflow to know what fails in production, what reviewer queues look like at scale, and what evaluation cadence actually catches drift. Reusable knowledge, not reusable code.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native lead qualification in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate lead qualification in medical devices with AI?+
We map the existing lead qualification workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction, and improve it weekly.
What does it cost to automate lead qualification for a medical devices company?+
Three phases, billed separately. Discovery sprint: $5k (2-week sprint). Build engagement: $15k–$22k (6-8 weeks). Run retainer: $2k–$3k / mo (optional, hourly bank also available). ~$25k–$45k typical year 1 (60% take the run option for ~6 months). Outbound, growth, or revenue-ops workflow, integration with your CRM, weekly operating review during Run.
What is the best AI agent for lead qualification in medical devices?+
There is no single "best" off-the-shelf agent for lead qualification in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI lead qualification for medical devices?+
A thin-slice deployment in 2-week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 6-8 weeks. By day 90, speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How do you measure revenue impact for lead qualification in medical devices?+
We instrument speed to lead, MQL to SQL conversion, sales acceptance rate, and wasted meeting reduction from day one, paired with sector-level metrics such as service resolution time, training completion, complaint cycle time, and rep productivity. We report against baseline weekly during Run, and we publish a 90-day impact recap.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Worldwide AI and Generative AI Spending Guide — IDC
- Hype Cycle for Artificial Intelligence — Gartner
- Generative AI Impact on Marketing & Sales — McKinsey
- B2B Sales Pulse Survey — Gartner for Sales
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.